In the feature ‘Successfully navigating the complexity of market access across Europe to improve health equity’, originally published in the European Biopharmaceutical Review, EVERSANA General Manager ...
The current OpenJDK 26 is strategically important and not only brings exciting innovations but also eliminates legacy issues like the outdated Applet API.